U.S. expert panel backs Pfizer's RSV vaccine for older adults

A sheet of extracurricular advisers to the U.S. wellness regulator connected Tuesday recommended Pfizer's respiratory syncytial microorganism (RSV) vaccine, bringing it person to becoming 1 of the archetypal approved RSV shots for older adults successful the United States.